Bruker Long Term Debt 2010-2023 | BRKR

Bruker long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • Bruker long term debt for the quarter ending December 31, 2023 was $1.160B, a 3.35% decline year-over-year.
  • Bruker long term debt for 2023 was $1.16B, a 3.35% decline from 2022.
  • Bruker long term debt for 2022 was $1.201B, a 1.74% decline from 2021.
  • Bruker long term debt for 2021 was $1.222B, a 45.06% increase from 2020.
Bruker Annual Long Term Debt
(Millions of US $)
2023 $1,160
2022 $1,201
2021 $1,222
2020 $842
2019 $813
2018 $323
2017 $416
2016 $392
2015 $265
2014 $354
2013 $354
2012 $336
2011 $219
2010 $87
2009 $116
Bruker Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $1,160
2023-09-30 $1,099
2023-06-30 $1,123
2023-03-31 $1,109
2022-12-31 $1,201
2022-09-30 $1,137
2022-06-30 $1,171
2022-03-31 $1,205
2021-12-31 $1,222
2021-09-30 $718
2021-06-30 $721
2021-03-31 $716
2020-12-31 $842
2020-09-30 $828
2020-06-30 $924
2020-03-31 $915
2019-12-31 $813
2019-09-30 $519
2019-06-30 $494
2019-03-31 $332
2018-12-31 $323
2018-09-30 $225
2018-06-30 $206
2018-03-31 $206
2017-12-31 $416
2017-09-30 $481
2017-06-30 $431
2017-03-31 $385
2016-12-31 $392
2016-09-30 $345
2016-06-30 $323
2016-03-31 $282
2015-12-31 $265
2015-09-30 $241
2015-06-30 $241
2015-03-31 $354
2014-12-31 $354
2014-09-30 $355
2014-06-30 $355
2014-03-31 $354
2013-12-31 $354
2013-09-30 $355
2013-06-30 $335
2013-03-31 $336
2012-12-31 $336
2012-09-30 $298
2012-06-30 $243
2012-03-31 $243
2011-12-31 $219
2011-09-30 $41
2011-06-30 $60
2011-03-31 $79
2010-12-31 $87
2010-09-30 $94
2010-06-30 $102
2010-03-31 $110
2009-12-31 $116
2009-09-30 $120
2009-06-30 $128
2009-03-31 $173
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $11.768B $2.965B
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.480B 32.51
Harvard Bioscience (HBIO) United States $0.157B 60.33
Kewaunee Scientific (KEQU) United States $0.099B 11.71